Indonesia · Delayed Price · Currency is IDR PT Suparma Tbk Statistics
Total Valuation
PT Suparma Tbk has a market cap or net worth of IDR 767.58 billion. The enterprise value is 1.71 trillion.
| Market Cap | 767.58B |
| Enterprise Value | 1.71T |
Important Dates
The next estimated earnings date is Thursday, November 5, 2026.
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
PT Suparma Tbk has 5.33 billion shares outstanding.
| Current Share Class | 5.33B |
| Shares Outstanding | 5.33B |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 0.02% |
| Float | 815.03M |
Valuation Ratios
The trailing PE ratio is 7.61.
| PE Ratio | 7.61 |
| Forward PE | n/a |
| PS Ratio | 0.26 |
| PB Ratio | 0.30 |
| P/TBV Ratio | 0.30 |
| P/FCF Ratio | 1.49 |
| P/OCF Ratio | 1.29 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.19, with an EV/FCF ratio of 3.31.
| EV / Earnings | 16.85 |
| EV / Sales | 0.58 |
| EV / EBITDA | 5.19 |
| EV / EBIT | 7.62 |
| EV / FCF | 3.31 |
Financial Position
The company has a current ratio of 1.71, with a Debt / Equity ratio of 0.41.
| Current Ratio | 1.71 |
| Quick Ratio | 0.37 |
| Debt / Equity | 0.41 |
| Debt / EBITDA | 3.18 |
| Debt / FCF | 2.03 |
| Interest Coverage | 4.93 |
Financial Efficiency
Return on equity (ROE) is 4.04% and return on invested capital (ROIC) is 5.51%.
| Return on Equity (ROE) | 4.04% |
| Return on Assets (ROA) | 3.65% |
| Return on Invested Capital (ROIC) | 5.51% |
| Return on Capital Employed (ROCE) | 6.94% |
| Weighted Average Cost of Capital (WACC) | 5.72% |
| Revenue Per Employee | 3.51B |
| Profits Per Employee | 120.45M |
| Employee Count | 840 |
| Asset Turnover | 0.77 |
| Inventory Turnover | 2.32 |
Taxes
In the past 12 months, PT Suparma Tbk has paid 19.12 billion in taxes.
| Income Tax | 19.12B |
| Effective Tax Rate | 15.89% |
Stock Price Statistics
The stock price has decreased by -35.96% in the last 52 weeks. The beta is 0.78, so PT Suparma Tbk's price volatility has been lower than the market average.
| Beta (5Y) | 0.78 |
| 52-Week Price Change | -35.96% |
| 50-Day Moving Average | 162.94 |
| 200-Day Moving Average | 166.87 |
| Relative Strength Index (RSI) | 34.56 |
| Average Volume (20 Days) | 238,170 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, PT Suparma Tbk had revenue of IDR 2.95 trillion and earned 101.18 billion in profits. Earnings per share was 18.93.
| Revenue | 2.95T |
| Gross Profit | 455.13B |
| Operating Income | 223.86B |
| Pretax Income | 120.30B |
| Net Income | 101.18B |
| EBITDA | 323.07B |
| EBIT | 223.86B |
| Earnings Per Share (EPS) | 18.93 |
Balance Sheet
The company has 108.29 billion in cash and 1.05 trillion in debt, with a net cash position of -937.53 billion or -175.88 per share.
| Cash & Cash Equivalents | 108.29B |
| Total Debt | 1.05T |
| Net Cash | -937.53B |
| Net Cash Per Share | -175.88 |
| Equity (Book Value) | 2.55T |
| Book Value Per Share | 478.92 |
| Working Capital | 626.29B |
Cash Flow
In the last 12 months, operating cash flow was 595.48 billion and capital expenditures -81.06 billion, giving a free cash flow of 514.43 billion.
| Operating Cash Flow | 595.48B |
| Capital Expenditures | -81.06B |
| Depreciation & Amortization | 120.22B |
| Net Borrowing | -730.25B |
| Free Cash Flow | 514.43B |
| FCF Per Share | 96.51 |
Margins
Gross margin is 15.43%, with operating and profit margins of 7.59% and 3.43%.
| Gross Margin | 15.43% |
| Operating Margin | 7.59% |
| Pretax Margin | 4.08% |
| Profit Margin | 3.43% |
| EBITDA Margin | 10.95% |
| EBIT Margin | 7.59% |
| FCF Margin | 18.28% |
Dividends & Yields
PT Suparma Tbk does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | 13.15% |
| FCF Yield | 67.02% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on July 9, 2026. It was a forward split with a ratio of 1.3.
| Last Split Date | Jul 9, 2026 |
| Split Type | Forward |
| Split Ratio | 1.3 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |